Currently, there are a total of ten FDA-approved indications for hGH therapy [5]: Growth hormone deficiency in children and adults (GHD) Growth failure due to chronic renal insufficiency Muscle wasting due to AIDS Noonan syndrome Prader-Willi syndrome Short bowel syndrome (SBS) Short stature homeobox (SHOX)-containing gene deficiency Small-for-gestational-age infants Turner syndrome Recombinant hGH therapy can effectively and dose-dependently increase serum GH levels, hence its use in managing the symptoms of GHD in children and adults
the fluid also contains several apoptotic mediators, such as TRAIL, perforin, granzyme, TNF-, soluble FasL, and granulysin [27, 31,32,33,34,35,36]
When combined with the tissue repair properties of BPC-157 and the systemic healing power of TB-500, the result is a comprehensive anti-aging protocol that works from the inside out
The levels of these proteins are notably elevated in patients with depression, suggesting their critical role in the disorder's pathogenesis [443,444,445]
References Shepherd BS, Johnson JK, Silverstein JT, et al
Daily research amount 300 mcg 5 mg + 1 mL BAC water 6 units 5 mg + 2 mL BAC water 12 units 5 mg + 3 mL BAC water 18 units Daily research amount 500 mcg 5 mg + 1 mL BAC water 10 units 5 mg + 2 mL BAC water 20 units 5 mg + 3 mL BAC water 30 units U-100 syringes contain 100 units per milliliter